Umeå University's logo

umu.sePublikasjoner
Endre søk
Link to record
Permanent link

Direct link
Bhattarai, Devi Prasad
Publikasjoner (4 av 4) Visa alla publikasjoner
Achour, C., Bhattarai, D. P., Groza, P., Roman, Á.-C. & Aguilo, F. (2023). METTL3 regulates breast cancer-associated alternative splicing switches. Oncogene, 42, 911-925
Åpne denne publikasjonen i ny fane eller vindu >>METTL3 regulates breast cancer-associated alternative splicing switches
Vise andre…
2023 (engelsk)Inngår i: Oncogene, ISSN 0950-9232, E-ISSN 1476-5594, Vol. 42, s. 911-925Artikkel i tidsskrift (Fagfellevurdert) Published
Abstract [en]

Alternative splicing (AS) enables differential inclusion of exons from a given transcript, thereby contributing to the transcriptome and proteome diversity. Aberrant AS patterns play major roles in the development of different pathologies, including breast cancer. N6-methyladenosine (m6A), the most abundant internal modification of eukaryotic mRNA, influences tumor progression and metastasis of breast cancer, and it has been recently linked to AS regulation. Here, we identify a specific AS signature associated with breast tumorigenesis in vitro. We characterize for the first time the role of METTL3 in modulating breast cancer-associated AS programs, expanding the role of the m6A-methyltransferase in tumorigenesis. Specifically, we find that both m6A deposition in splice site boundaries and in splicing and transcription factor transcripts, such as MYC, direct AS switches of specific breast cancer-associated transcripts. Finally, we show that five of the AS events validated in vitro are associated with a poor overall survival rate for patients with breast cancer, suggesting the use of these AS events as a novel potential prognostic biomarker.

sted, utgiver, år, opplag, sider
Nature Publishing Group, 2023
HSV kategori
Forskningsprogram
molekylärbiologi
Identifikatorer
urn:nbn:se:umu:diva-194175 (URN)10.1038/s41388-023-02602-z (DOI)000925962300003 ()36725888 (PubMedID)2-s2.0-85147175928 (Scopus ID)
Forskningsfinansiär
Knut and Alice Wallenberg FoundationRegion VästerbottenSwedish Research Council, 2017-01636Swedish Cancer Society, 19 0337 PjThe Kempe Foundations, SMK-1766Cancerforskningsfonden i Norrland, LP 16-2126
Tilgjengelig fra: 2022-04-26 Laget: 2022-04-26 Sist oppdatert: 2024-04-08bibliografisk kontrollert
Bhattarai, D. P. & Aguilo, F. (2022). m6A RNA immunoprecipitation followed by high-throughput sequencing to map N6-Methyladenosine (3ed.). In: Erik Dassi (Ed.), Post-transcriptional gene regulation: (pp. 355-362). Humana Press
Åpne denne publikasjonen i ny fane eller vindu >>m6A RNA immunoprecipitation followed by high-throughput sequencing to map N6-Methyladenosine
2022 (engelsk)Inngår i: Post-transcriptional gene regulation / [ed] Erik Dassi, Humana Press, 2022, 3, , s. 8s. 355-362Kapittel i bok, del av antologi (Fagfellevurdert)
Abstract [en]

N6-methyladenosine (m6A) is the most abundant internal modification on messenger RNAs (mRNAs) and long noncoding RNAs (lncRNAs) in eukaryotes. It influences gene expression by regulating RNA processing, nuclear export, mRNA decay, and translation. Hence, m6A controls fundamental cellular processes, and dysregulated deposition of m6A has been acknowledged to play a role in a broad range of human diseases, including cancer. m6A RNA immunoprecipitation followed by high-throughput sequencing (MeRIP-seq or m6A-seq) is a powerful technique to map m6A in a transcriptome-wide level. After immunoprecipitation of fragmented polyadenylated (poly(A)+) rich RNA by using specific anti-m6A antibodies, both the immunoprecipitated RNA fragments together with the input control are subjected to massively parallel sequencing. The generation of such comprehensive methylation profiles of signal enrichment relative to input control is necessary in order to better comprehend the pathogenesis behind aberrant m6A deposition.

sted, utgiver, år, opplag, sider
Humana Press, 2022. s. 8 Opplag: 3
Serie
Methods in Molecular Biology (MIMB), ISSN 1064-3745, E-ISSN 1940-6029 ; 2404
Emneord
Epitranscriptomics, MeRIP-seq or m6A-seq, METTL3, N6-Methyladenosine
HSV kategori
Identifikatorer
urn:nbn:se:umu:diva-189549 (URN)10.1007/978-1-0716-1851-6_19 (DOI)2-s2.0-85118431040 (Scopus ID)9781071618516 (ISBN)9781071618509 (ISBN)
Forskningsfinansiär
Region VästerbottenKnut and Alice Wallenberg FoundationSwedish Research Council, 2017-01636The Kempe Foundations, 19 0337 Pj, SMK-1766
Tilgjengelig fra: 2021-11-16 Laget: 2021-11-16 Sist oppdatert: 2022-03-08bibliografisk kontrollert
Malla, S., Bhattarai, D. P., Groza, P., Melguizo-Sanchis, D., Atanasoai, I., Martinez Gamero, C., . . . Aguilo, F. (2022). ZFP207 sustains pluripotency by coordinating OCT4 stability, alternative splicing and RNA export. EMBO Reports, 23(3), Article ID e53191.
Åpne denne publikasjonen i ny fane eller vindu >>ZFP207 sustains pluripotency by coordinating OCT4 stability, alternative splicing and RNA export
Vise andre…
2022 (engelsk)Inngår i: EMBO Reports, ISSN 1469-221X, E-ISSN 1469-3178, Vol. 23, nr 3, artikkel-id e53191Artikkel i tidsskrift (Fagfellevurdert) Published
Abstract [en]

The pluripotent state is not solely governed by the action of the core transcription factors OCT4, SOX2, and NANOG, but also by a series of co-transcriptional and post-transcriptional events, including alternative splicing (AS) and the interaction of RNA-binding proteins (RBPs) with defined subpopulations of RNAs. Zinc Finger Protein 207 (ZFP207) is an essential transcription factor for mammalian embryonic development. Here, we employ multiple functional analyses to characterize its role in mouse embryonic stem cells (ESCs). We find that ZFP207 plays a pivotal role in ESC maintenance, and silencing of Zfp207 leads to severe neuroectodermal differentiation defects. In striking contrast to human ESCs, mouse ZFP207 does not transcriptionally regulate neuronal and stem cell-related genes but exerts its effects by controlling AS networks and by acting as an RBP. Our study expands the role of ZFP207 in maintaining ESC identity, and underscores the functional versatility of ZFP207 in regulating neural fate commitment.

sted, utgiver, år, opplag, sider
John Wiley & Sons, 2022
HSV kategori
Identifikatorer
urn:nbn:se:umu:diva-191672 (URN)10.15252/embr.202153191 (DOI)000743102200001 ()35037361 (PubMedID)2-s2.0-85122763926 (Scopus ID)
Tilgjengelig fra: 2022-01-21 Laget: 2022-01-21 Sist oppdatert: 2024-04-08bibliografisk kontrollert
Achour, C., Bhattarai, D. P., Esteva-Socias, M., Rodriguez-Barrueco, R., Malla, S., Seier, K., . . . Aguilo, F.Reshaping the role of METTL3 in breast tumorigenesis.
Åpne denne publikasjonen i ny fane eller vindu >>Reshaping the role of METTL3 in breast tumorigenesis
Vise andre…
(engelsk)Manuskript (preprint) (Annet vitenskapelig)
HSV kategori
Identifikatorer
urn:nbn:se:umu:diva-201048 (URN)
Tilgjengelig fra: 2022-11-16 Laget: 2022-11-16 Sist oppdatert: 2024-03-22
Organisasjoner